216 related articles for article (PubMed ID: 30811983)
1. PRMT5 Modulates Splicing for Genome Integrity and Preserves Proteostasis of Hematopoietic Stem Cells.
Tan DQ; Li Y; Yang C; Li J; Tan SH; Chin DWL; Nakamura-Ishizu A; Yang H; Suda T
Cell Rep; 2019 Feb; 26(9):2316-2328.e6. PubMed ID: 30811983
[TBL] [Abstract][Full Text] [Related]
2. Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis.
Liu F; Cheng G; Hamard PJ; Greenblatt S; Wang L; Man N; Perna F; Xu H; Tadi M; Luciani L; Nimer SD
J Clin Invest; 2015 Sep; 125(9):3532-44. PubMed ID: 26258414
[TBL] [Abstract][Full Text] [Related]
3. The protein arginine methyltransferase PRMT5 confers therapeutic resistance to mTOR inhibition in glioblastoma.
Holmes B; Benavides-Serrato A; Saunders JT; Landon KA; Schreck AJ; Nishimura RN; Gera J
J Neurooncol; 2019 Oct; 145(1):11-22. PubMed ID: 31473880
[TBL] [Abstract][Full Text] [Related]
4. PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes.
Hamard PJ; Santiago GE; Liu F; Karl DL; Martinez C; Man N; Mookhtiar AK; Duffort S; Greenblatt S; Verdun RE; Nimer SD
Cell Rep; 2018 Sep; 24(10):2643-2657. PubMed ID: 30184499
[TBL] [Abstract][Full Text] [Related]
5. Selective PRMT5 Inhibitors Suppress Human CD8
Strobl CD; Schaffer S; Haug T; Völkl S; Peter K; Singer K; Böttcher M; Mougiakakos D; Mackensen A; Aigner M
Mol Cancer Ther; 2020 Feb; 19(2):409-419. PubMed ID: 31712395
[TBL] [Abstract][Full Text] [Related]
6. PRMT5-mediated homologous recombination repair is essential to maintain genomic integrity of neural progenitor cells.
Wang YJ; Cao JB; Yang J; Liu T; Yu HL; He ZX; Bao SL; He XX; Zhu XJ
Cell Mol Life Sci; 2024 Mar; 81(1):123. PubMed ID: 38459149
[TBL] [Abstract][Full Text] [Related]
7. The protein arginine methyltransferase PRMT5 regulates Aβ-induced toxicity in human cells and Caenorhabditis elegans models of Alzheimer's disease.
Quan X; Yue W; Luo Y; Cao J; Wang H; Wang Y; Lu Z
J Neurochem; 2015 Sep; 134(5):969-77. PubMed ID: 26086249
[TBL] [Abstract][Full Text] [Related]
8. The Fanconi anemia pathway controls oncogenic response in hematopoietic stem and progenitor cells by regulating PRMT5-mediated p53 arginine methylation.
Du W; Amarachintha S; Erden O; Wilson A; Pang Q
Oncotarget; 2016 Sep; 7(37):60005-60020. PubMed ID: 27507053
[TBL] [Abstract][Full Text] [Related]
9. PRMT5 is essential for B cell development and germinal center dynamics.
Litzler LC; Zahn A; Meli AP; Hébert S; Patenaude AM; Methot SP; Sprumont A; Bois T; Kitamura D; Costantino S; King IL; Kleinman CL; Richard S; Di Noia JM
Nat Commun; 2019 Jan; 10(1):22. PubMed ID: 30604754
[TBL] [Abstract][Full Text] [Related]
10. Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing.
Gerhart SV; Kellner WA; Thompson C; Pappalardi MB; Zhang XP; Montes de Oca R; Penebre E; Duncan K; Boriack-Sjodin A; Le B; Majer C; McCabe MT; Carpenter C; Johnson N; Kruger RG; Barbash O
Sci Rep; 2018 Jun; 8(1):9711. PubMed ID: 29946150
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hematopoietic stem cell integrity through p53 and its related factors.
Yamashita M; Nitta E; Suda T
Ann N Y Acad Sci; 2016 Apr; 1370(1):45-54. PubMed ID: 26695737
[TBL] [Abstract][Full Text] [Related]
12. SRSF3 and HNRNPH1 Regulate Radiation-Induced Alternative Splicing of Protein Arginine Methyltransferase 5 in Hepatocellular Carcinoma.
Wen C; Tian Z; Li L; Chen T; Chen H; Dai J; Liang Z; Ma S; Liu X
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499164
[TBL] [Abstract][Full Text] [Related]
13. A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.
Du C; Hansen LJ; Singh SX; Wang F; Sun R; Moure CJ; Roso K; Greer PK; Yan H; He Y
Cell Rep; 2019 Sep; 28(12):3199-3211.e5. PubMed ID: 31533041
[TBL] [Abstract][Full Text] [Related]
14. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers.
Li Y; Chitnis N; Nakagawa H; Kita Y; Natsugoe S; Yang Y; Li Z; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
Cancer Discov; 2015 Mar; 5(3):288-303. PubMed ID: 25582697
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for substrate recruitment to the PRMT5 methylosome.
Mulvaney KM; Blomquist C; Acharya N; Li R; Ranaghan MJ; O'Keefe M; Rodriguez DJ; Young MJ; Kesar D; Pal D; Stokes M; Nelson AJ; Jain SS; Yang A; Mullin-Bernstein Z; Columbus J; Bozal FK; Skepner A; Raymond D; LaRussa S; McKinney DC; Freyzon Y; Baidi Y; Porter D; Aguirre AJ; Ianari A; McMillan B; Sellers WR
Mol Cell; 2021 Sep; 81(17):3481-3495.e7. PubMed ID: 34358446
[TBL] [Abstract][Full Text] [Related]
16. PRMT5 methylome profiling uncovers a direct link to splicing regulation in acute myeloid leukemia.
Radzisheuskaya A; Shliaha PV; Grinev V; Lorenzini E; Kovalchuk S; Shlyueva D; Gorshkov V; Hendrickson RC; Jensen ON; Helin K
Nat Struct Mol Biol; 2019 Nov; 26(11):999-1012. PubMed ID: 31611688
[TBL] [Abstract][Full Text] [Related]
17. [Maintenance of hematopoietic stem cell integrity and regulation of leukemogenesis by p53 and its coactivator Aspp1].
Yamashita M; Nitta E; Suda T
Rinsho Ketsueki; 2015 Dec; 56(12):2426-33. PubMed ID: 26725350
[TBL] [Abstract][Full Text] [Related]
18. PRMT5 is required for cell-cycle progression and p53 tumor suppressor function.
Scoumanne A; Zhang J; Chen X
Nucleic Acids Res; 2009 Aug; 37(15):4965-76. PubMed ID: 19528079
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
Sloan SL; Brown F; Long M; Weigel C; Koirala S; Chung JH; Pray B; Villagomez L; Hinterschied C; Sircar A; Helmig-Mason J; Prouty A; Brooks E; Youssef Y; Hanel W; Parekh S; Chan WK; Chen Z; Lapalombella R; Sehgal L; Vaddi K; Scherle P; Chen-Kiang S; Di Liberto M; Elemento O; Meydan C; Foox J; Butler D; Mason CE; Baiocchi RA; Alinari L
Blood; 2023 Sep; 142(10):887-902. PubMed ID: 37267517
[TBL] [Abstract][Full Text] [Related]
20. NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms.
Webb LM; Narvaez Miranda J; Amici SA; Sengupta S; Nagy G; Guerau-de-Arellano M
Front Immunol; 2019; 10():524. PubMed ID: 30941147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
